Lazard Asset Management LLC Grows Stock Holdings in AdaptHealth Corp. $AHCO

Lazard Asset Management LLC boosted its stake in shares of AdaptHealth Corp. (NASDAQ:AHCO) by 35.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,669,454 shares of the company’s stock after buying an additional 432,664 shares during the quarter. Lazard Asset Management LLC’s holdings in AdaptHealth were worth $19,867,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Rockefeller Capital Management L.P. lifted its position in shares of AdaptHealth by 433.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock valued at $26,000 after acquiring an additional 2,100 shares during the period. PNC Financial Services Group Inc. boosted its stake in shares of AdaptHealth by 22.3% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after acquiring an additional 1,279 shares in the last quarter. Assetmark Inc. grew its holdings in shares of AdaptHealth by 54.8% in the 1st quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock worth $83,000 after acquiring an additional 2,460 shares during the period. Tower Research Capital LLC TRC grew its holdings in shares of AdaptHealth by 318.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after acquiring an additional 7,297 shares during the period. Finally, Tidal Investments LLC acquired a new stake in shares of AdaptHealth in the 2nd quarter worth approximately $96,000. 82.67% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts recently issued reports on AHCO shares. Robert W. Baird reduced their price objective on AdaptHealth from $18.00 to $15.00 and set an “outperform” rating for the company in a report on Monday, July 6th. UBS Group lowered their target price on AdaptHealth from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday, May 6th. Truist Financial upped their target price on AdaptHealth from $13.00 to $14.00 and gave the company a “buy” rating in a report on Monday, April 13th. Weiss Ratings restated a “sell (d)” rating on shares of AdaptHealth in a research report on Friday, May 22nd. Finally, Jefferies Financial Group raised AdaptHealth from a “hold” rating to a “buy” rating and lifted their price target for the stock from $11.00 to $13.00 in a research note on Tuesday, July 21st. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, AdaptHealth presently has an average rating of “Moderate Buy” and an average price target of $14.14.

Insider Buying and Selling at AdaptHealth

In other news, insider Russell E. Schuster III sold 11,275 shares of the company’s stock in a transaction on Monday, June 1st. The stock was sold at an average price of $10.06, for a total value of $113,426.50. Following the sale, the insider directly owned 136,538 shares in the company, valued at $1,373,572.28. This represents a 7.63% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is currently owned by company insiders.

AdaptHealth Price Performance

Shares of NASDAQ:AHCO opened at $11.22 on Wednesday. The business’s fifty day moving average price is $10.27 and its two-hundred day moving average price is $10.67. The stock has a market cap of $1.52 billion, a PE ratio of -18.10, a price-to-earnings-growth ratio of 0.56 and a beta of 1.45. The company has a debt-to-equity ratio of 1.21, a quick ratio of 0.71 and a current ratio of 0.92. AdaptHealth Corp. has a one year low of $8.51 and a one year high of $13.43.

AdaptHealth Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.